DYPREK Trademark

Trademark Overview

On Friday, October 23, 2009, a trademark application was filed for DYPREK with the United States Patent and Trademark Office. The USPTO has given the DYPREK trademark a serial number of 77855725. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2013. This trademark is owned by Glaxo Group Limited. The DYPREK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
dyprek

General Information

Serial Number77855725
Word MarkDYPREK
Filing DateFriday, October 23, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 28, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 1, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 1, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 26, 2012EXTENSION 5 GRANTED
Tuesday, November 20, 2012EXTENSION 5 FILED
Tuesday, November 20, 2012TEAS EXTENSION RECEIVED
Tuesday, May 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 21, 2012EXTENSION 4 GRANTED
Wednesday, May 16, 2012EXTENSION 4 FILED
Wednesday, May 16, 2012TEAS EXTENSION RECEIVED
Wednesday, November 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2011EXTENSION 3 GRANTED
Friday, November 4, 2011EXTENSION 3 FILED
Friday, November 4, 2011TEAS EXTENSION RECEIVED
Wednesday, June 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 7, 2011EXTENSION 2 GRANTED
Sunday, May 1, 2011EXTENSION 2 FILED
Wednesday, June 1, 2011TEAS EXTENSION RECEIVED
Wednesday, November 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 2, 2010EXTENSION 1 GRANTED
Tuesday, October 19, 2010EXTENSION 1 FILED
Tuesday, November 2, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 19, 2010TEAS EXTENSION RECEIVED
Tuesday, June 1, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 2, 2010ASSIGNED TO LIE
Thursday, February 4, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2010ASSIGNED TO EXAMINER
Wednesday, October 28, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 27, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

dyprek pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic